The chemical substance known as (2R,3R)-3-(1H-benzimidazol-2-yl)-2,3-dihydroxypropanoate, with the CAS number 49671-84-3, is a derivative of propanoic acid featuring a benzimidazole moiety. This compound is characterized by its chiral centers at the 2 and 3 positions of the propanoate backbone, which contributes to its stereochemical properties. The presence of hydroxyl groups at the 2 and 3 positions enhances its solubility in polar solvents and may influence its biological activity. Benzimidazole derivatives are often noted for their pharmacological properties, including potential antimicrobial and anti-inflammatory effects. The compound's structure suggests it may participate in hydrogen bonding due to the hydroxyl groups and the nitrogen in the benzimidazole ring, which could affect its interactions with biological targets. Overall, this substance is of interest in medicinal chemistry and may have applications in drug development, although specific biological activities and therapeutic uses would require further investigation.

(2R,3R)-3-(1H-benzimidazol-2-yl)-2,3-dihydroxypropanoate

49671-84-3: The chemical substance known as (2R,3R)-3-(1H-benzimidazol-2-yl)-2,3-dihydroxypropanoate, with the CAS number 49671-84-3, is a derivative of propanoic acid featuring a benzimidazole moiety. This compound is characterized by its chiral centers at the 2 and 3 positions of the propanoate backbone, which contributes to its stereochemical properties. The presence of hydroxyl groups at the 2 and 3 positions enhances its solubility in polar solvents and may influence its biological activity. Benzimidazole derivatives are often noted for their pharmacological properties, including potential antimicrobial and anti-inflammatory effects. The compound's structure suggests it may participate in hydrogen bonding due to the hydroxyl groups and the nitrogen in the benzimidazole ring, which could affect its interactions with biological targets. Overall, this substance is of interest in medicinal chemistry and may have applications in drug development, although specific biological activities and therapeutic uses would require further investigation.

CAS 49671-84-3

(2R,3R)-3-(1H-benzimidazol-2-yl)-2,3-dihydroxypropanoate

3-(1H -Benzoimidazol-2-yl)-2,3-dihydroxy-propionic acid

Ref: 10-F027632